Transient, subclinical atrial fibrillation and risk of systemic embolism in patients with rheumatic mitral stenosis in sinus rhythm

American Journal of Cardiology

Volumn 114, Issue 6, 2014, Pages 869-874

  Karthikeyan, Ganesan ^a   Ananthakrishnan, Ramamoorthy ^a   Devasenapathy, Niveditha ^b   Narang, Rajiv ^a   Yadav, Rakesh ^a   Seth, Sandeep ^a   Singh, Sandeep ^a   Goswami, Kewal C ^a   Bahl, Vinay K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Indian Institute of Public Health   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULATION; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLINDNESS; CENTRAL RETINA ARTERY OCCLUSION; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEMIPLEGIA; HOLTER MONITORING; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RHEUMATIC HEART DISEASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL VALVULOPLASTY; TRICUSPID VALVE REGURGITATION;

EID: 84926189654     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.06.016     Document Type: Article

References (16)

1. Wang D, Liu M, Lin S, Hao Z, Tao W, Chen X, Luan R, Dong W. Stroke and rheumatic heart disease: a systematic review of observational studies. Clin Neurol Neurosurg 2013;115:1575-1582.
2. Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Med J 1964;1:1209-1212.
3. Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E. Systemic embolism in mitral valve disease. Br Heart J 1970;32:26-34.
4. Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH; American College of Chest Physicians. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141:e576See600S.
5. Ramsdale DR, Arumugam N, Singh SS, Pearson J, Charles RG. Holter monitoring in patients with mitral stenosis and sinus rhythm. Eur Heart J 1987;8:164-170.
6. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-e142.
7. Fatkin D, Herbert E, Feneley MP. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 1994;73:672-676.
8. Chiang CW, Lo SK, Ko YS, Cheng NJ, Lin PJ, Chang CH. Predictors of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med 1998;128:885-889.
9. Bannister RG. The risks of deferring valvotomy in patients with moderate mitral stenosis. Lancet 1960;2:329-333.
10. Fleming HA, Bailey SM. Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 1971;47:599-604.
11. Goswami KC, Yadav R, Rao MB, Bahl VK, Talwar KK, Manchanda SC. Clinical and echocardiographic predictors of left atrial clot and spontaneous echo contrast in patients with severe rheumatic mitral stenosis: a prospective study in 200 patients by transesophageal echocardiography. Int J Cardiol 2000;73:273-279.
12. Kasliwal RR, Mittal S, Kanojia A, Singh RP, Prakash O, Bhatia ML, Trehan N. A study of spontaneous echo contrast in patients with rheumatic mitral stenosis and normal sinus rhythm: an Indian perspective. Br Heart J 1995;74:296-299.
13. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH, Investigators A. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366: 120-129.
14. Karthikeyan G, Zuhlke L, Engel M, Rangarajan S, Yusuf S, Teo K, Mayosi BM. Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study. Am Heart J 2012;163:535-540.
15. Parakh N, Chaturvedi V. Indigenous telemedicine. Indian Pacing Electrophysiol J 2012;12:131-132.
16. Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, Pais P, Dans A, Eikelboom J, Oldgren J, Pogue J, Reilly PA, Yang S, Connolly SJ. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010;376:975-983.